• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1994年意大利药品政策中的文化转变:一个案例史。

The cultural shift in Italy's pharmaceutical policy in 1994: a case history.

作者信息

Garattini Silvio

机构信息

Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.

出版信息

J Ambul Care Manage. 2004 Apr-Jun;27(2):120-6. doi: 10.1097/00004479-200404000-00007.

DOI:10.1097/00004479-200404000-00007
PMID:15069989
Abstract

The advent of the National Health Service in 1978 in Italy also resulted in the compilation of a formulary of pharmaceutical products to be distributed free of charge. During the subsequent years the formulary increased in size with the introduction of new drugs and consequently pharmaceutical expenses increased steadily, reaching a peak in 1992. The years preceding this peak of expenses were characterized by pervasive corruption that involved several government civil servants and even the Minister of Health, as well as several members of the national committees responsible for the approval and pricing of medicinal products. The present article summarizes the events from 1992 in Italy when the revelation of corruption in the healthcare system and the pressure of public opinion obliged the authorities to make drastic changes in the pharmaceutical policy, and also introduces and discusses the reactions and the impact of such changes on pharmaceutical expenses and drug utilization over the following years.

摘要

1978年意大利国家医疗服务体系的出现,也促成了一份免费分发药品的处方集的编纂。在随后的几年里,随着新药的引入,处方集的规模不断扩大,药品费用也随之稳步上升,在1992年达到顶峰。在费用达到峰值之前的几年里,普遍存在腐败现象,涉及多名政府公务员甚至卫生部长,以及负责药品审批和定价的国家委员会的几名成员。本文总结了1992年以来意大利的事件,当时医疗体系腐败的揭露和舆论压力迫使当局对药品政策进行大刀阔斧的改革,并介绍和讨论了这些改革在接下来几年里对药品费用和药物使用的反应及影响。

相似文献

1
The cultural shift in Italy's pharmaceutical policy in 1994: a case history.1994年意大利药品政策中的文化转变:一个案例史。
J Ambul Care Manage. 2004 Apr-Jun;27(2):120-6. doi: 10.1097/00004479-200404000-00007.
2
Cultural shift in Italy's drug policy.意大利毒品政策的文化转变。
Lancet. 1995 Jul 1;346(8966):5-6. doi: 10.1016/s0140-6736(95)92647-x.
3
[Impact Reimbursement Act on the pharmaceutical market in Poland].[《影响波兰药品市场的报销法案》]
Pol Merkur Lekarski. 2014 Apr;36(214):270-3.
4
[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].[丹麦制药行业的早期成就——8. 灵北公司]
Theriaca. 2016(43):9-61.
5
Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity.制药公司与意大利地方政府:在日益复杂的制度环境中管理关系
Health Policy. 2008 Sep;87(3):333-41. doi: 10.1016/j.healthpol.2008.02.010. Epub 2008 Apr 1.
6
Drug Policy in Latvia.拉脱维亚的毒品政策。
Value Health Reg Issues. 2017 Sep;13:73-78. doi: 10.1016/j.vhri.2017.08.006. Epub 2017 Sep 28.
7
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines.意大利政府在药品发现、开发和获取方面的政策。
Clin Ther. 2018 Nov;40(11):1931-1940. doi: 10.1016/j.clinthera.2018.09.015. Epub 2018 Oct 27.
8
[Early achievements of the Danish pharmaceutical industry-7].[丹麦制药行业的早期成就 - 7]
Theriaca. 2014(42):31-62.
9
Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.平衡制药行业的健康与产业政策目标:来自澳大利亚的经验教训。
Health Policy. 2008 Aug;87(2):133-45. doi: 10.1016/j.healthpol.2008.01.003. Epub 2008 Mar 4.
10
Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status.
Int Clin Psychopharmacol. 2001 Jul;16(4):227-33. doi: 10.1097/00004850-200107000-00007.